T1	Disorder 1593 1600	disease
T6	Method_cue 882 887	ELISA
T7	Artificial_process 748 758	collection
T11	Subject 984 990	cohort
T22	Disorder 571 574	SSc
T25	Disorder 305 312	disease
T26	Subject 1770 1778	patients
T31	Disorder 182 207	interstitial lung disease
T32	Disorder 282 293	scleroderma
T34	Disorder 209 212	ILD
T36	Anatomical_entity 346 351	serum
T37	Anatomical_entity 857 862	serum
T38	GGPs 448 474	fibroblast growth factor 2
T40	Measurement 1249 1252	FVC
T43	GGPs 391 396	IL-10
T47	Measurement 1041 1045	DLCO
T48	GGPs 412 446	vascular endothelial growth factor
T51	Artificial_process 240 264	therapeutic intervention
T52	Disorder 79 104	interstitial lung disease
T53	Disorder 1062 1065	IPF
T54	Anatomical_entity 742 747	serum
T55	Anatomical_entity 997 1002	serum
T56	Subject 579 590	58 patients
T58	Measurement 1459 1462	FVC
T60	Disorder 627 630	IPF
T61	Disorder 1074 1077	ILD
T62	Measurement 1287 1291	DLCO
T63	Subject 919 925	cohort
T65	GGPs 352 361	cytokines
T67	Subject 929 941	212 patients
T68	Measurement 705 708	FVC
T69	Subject 1572 1580	patients
T71	Anatomical_entity 1474 1479	serum
T72	Disorder 951 954	ILD
T73	Subject 1185 1191	cohort
T75	Disorder 318 321	ILD
T76	Disorder 596 625	idiopathic pulmonary fibrosis
T79	GGPs 398 402	CCL2
T80	Subject 554 565	74 patients
T86	Measurement 1123 1127	DLCO
T87	GGPs 404 410	CXCL10
T88	Anatomical_entity 0 5	Serum
T89	GGPs 6 19	interleukin 6
T91	Artificial_process 1822 1831	treatment
T97	Anatomical_entity 1696 1701	serum
T102	Measurement 717 721	DLCO
T103	Disorder 121 139	systemic sclerosis
T104	Disorder 1691 1694	ILD
T105	Subject 268 276	patients
T110	Anatomical_entity 1193 1198	serum
T111	Subject 543 550	cohorts
E1	Artificial_process:T7 Theme:T54
E2	Artificial_process:T51 Theme:T105
E4	Artificial_process:T91 Theme:T4
N1	Reference T1 UMLS:C0012634	Disease
N20	Reference T6 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
N22	Reference E1 UMLS:C1516698	Collection (action)
N33	Reference T11 UMLS:C0599755	Cohort
N76	Reference T25 UMLS:C0012634	Disease
N78	Reference T26 UMLS:C0030705	Patients
N95	Reference T31 UMLS:C0206062	Lung Diseases, Interstitial
N99	Reference T32 UMLS:C0011644	Scleroderma
N107	Reference T34 UMLS:C0206062	Lung Diseases, Interstitial
N115	Reference T36 UMLS:C0229671	Serum
N120	Reference T37 UMLS:C0229671	Serum
N132	Reference T40 UMLS:C3714541	Forced Vital Capacity
N155	Reference T47 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N170	Reference T52 UMLS:C0206062	Lung Diseases, Interstitial
N173	Reference T53 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N179	Reference T54 UMLS:C0229671	Serum
N184	Reference T55 UMLS:C0229671	Serum
N185	Reference T56 UMLS:C0030705	Patients
N192	Reference T58 UMLS:C3714541	Forced Vital Capacity
N195	Reference T60 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N198	Reference T61 UMLS:C0206062	Lung Diseases, Interstitial
N200	Reference T62 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N202	Reference T63 UMLS:C0599755	Cohort
N211	Reference T65 UMLS:C0079189	cytokine
N215	Reference T67 UMLS:C0030705	Patients
N218	Reference T68 UMLS:C3714541	Forced Vital Capacity
N219	Reference T69 UMLS:C0030705	Patients
N227	Reference T71 UMLS:C0229671	Serum
N228	Reference T72 UMLS:C0206062	Lung Diseases, Interstitial
N230	Reference T73 UMLS:C0599755	Cohort
N236	Reference T75 UMLS:C0206062	Lung Diseases, Interstitial
N238	Reference T76 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N249	Reference T80 UMLS:C0030705	Patients
N274	Reference T86 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N282	Reference T88 UMLS:C0229671	Serum
N284	Reference T89 UMLS:C0021760	Interleukin-6
N298	Reference E4 UMLS:C0087111	Therapeutic procedure
N327	Reference T97 UMLS:C0229671	Serum
N342	Reference T102 UMLS:C1516251	Carbon Monoxide Diffusing Capability Test
N344	Reference T103 UMLS:C0036421	Systemic Scleroderma
N346	Reference T104 UMLS:C0206062	Lung Diseases, Interstitial
N348	Reference T105 UMLS:C0030705	Patients
N370	Reference T110 UMLS:C0229671	Serum
N371	Reference T111 UMLS:C0599755	Cohort
T20	Disorder 1660 1670	severe ILD
N2	Reference T20 UMLS:C0206062	Lung Diseases, Interstitial
T29	Disorder 1667 1670	ILD
N3	Reference T29 UMLS:C0206062	Lung Diseases, Interstitial
T114	Entity_Property 1660 1666	severe
N5	Reference T114 UMLS:C0205082	Severe (severity modifier)
T115	Disorder 1784 1792	mild ILD
N9	Reference T115 UMLS:C0206062	Lung Diseases, Interstitial
T21	Entity_Property 1784 1788	mild
N21	Reference T21 UMLS:C2945599	Mild (qualifier value)
T59	Disorder 1789 1792	ILD
N23	Reference T59 UMLS:C0206062	Lung Diseases, Interstitial
T117	GGPs 385 389	IL-8
N28	Reference T117 UMLS:C0079633	Interleukin-8
N29	Reference T87 UMLS:C0056978	Chemokine CXCL10
T118	GGPs 363 376	interleukin 6
N30	Reference T118 UMLS:C0021760	Interleukin-6
T119	GGPs 378 382	IL-6
N32	Reference T119 UMLS:C0021760	Interleukin-6
T120	GGPs 863 867	IL-6
N35	Reference T120 UMLS:C0021760	Interleukin-6
T121	GGPs 1003 1007	IL-6
N36	Reference T121 UMLS:C0021760	Interleukin-6
T122	GGPs 1083 1087	IL-6
N37	Reference T122 UMLS:C0021760	Interleukin-6
T123	GGPs 1199 1203	IL-6
N38	Reference T123 UMLS:C0021760	Interleukin-6
T124	GGPs 1480 1484	IL-6
N40	Reference T124 UMLS:C0021760	Interleukin-6
T125	GGPs 1702 1706	IL-6
N41	Reference T125 UMLS:C0021760	Interleukin-6
N42	Reference T43 UMLS:C0085295	Interleukin-10
N43	Reference T79 UMLS:C0128897	Monocyte Chemoattractant Protein-1
N46	Reference T38 UMLS:C0380603	Fibroblast Growth Factor 2
T126	GGPs 480 486	CX3CL1
N47	Reference T126 UMLS:C0535298	Fractalkine
N50	Reference T48 UMLS:C0078058	Vascular Endothelial Growth Factor A
T4	Subject 1840 1845	group
N8	Reference T4 UMLS:C1257890	Population Group
R2	Subject_Disorder Arg1:T80 Arg2:T22	
R3	Subject_Disorder Arg1:T56 Arg2:T76	
R1	Subject_Disorder Arg1:T26 Arg2:T115	
R4	Subject_Disorder Arg1:T105 Arg2:T32	
T127	Negative_regulation 673 680	decline
E8	Negative_regulation:T127 Theme:E15 Cue:T18 Cue2:T16
N12	Reference E8 UMLS:C3463820	Inhibition
T128	Negative_regulation 1046 1053	decline
E9	Negative_regulation:T128 Theme:T47 disorder:T61
N34	Reference E9 UMLS:C3463820	Inhibition
T129	Negative_regulation 1128 1135	decline
E10	Negative_regulation:T129 Theme:T86
N51	Reference E10 UMLS:C3463820	Inhibition
T130	Negative_regulation 1238 1245	decline
E11	Negative_regulation:T130 Theme:T40
N54	Reference E11 UMLS:C3463820	Inhibition
T132	Subject 543 550	cohorts
N59	Reference T132 UMLS:C0599755	Cohort
R5	member_of Arg1:T80 Arg2:T132	
R6	member_of Arg1:T56 Arg2:T111	
R7	member_of Arg1:T67 Arg2:T63	
T136	Biological_process 659 672	lung function
E15	Biological_process:T136 
T28	Measurement 682 703	forced vital capacity
N57	Reference T28 UMLS:C3714541	Forced Vital Capacity
T9	Disorder 314 317	SSc
R12	Disorder_association Arg1:T52 Arg2:T103	
R13	Disorder_association Arg1:T32 Arg2:T25	
R14	Disorder_association Arg1:T9 Arg2:T75	
R15	Subject_Disorder Arg1:T105 Arg2:T25	
T13	Biological_process 167 178	progression
E12	Biological_process:T13 Theme:T31
N14	Reference E12 UMLS:C0242656	Disease Progression
E3	Negative_regulation:T128 Theme:T47 disorder:T53
N16	Reference E3 UMLS:C3463820	Inhibition
E6	Negative_regulation:T130 Theme:T62
N17	Reference E6 UMLS:C3463820	Inhibition
T15	Biological_process 1755 1766	progression
E7	Biological_process:T15 Theme:T115
N18	Reference E7 UMLS:C0242656	Disease Progression
R16	Subject_Disorder Arg1:T67 Arg2:T72	
T16	Method_cue 777 806	proportional hazards analysis
N11	Reference T16 UMLS:C0033489	Proportional Hazards Models
T18	Speculation_cue 764 773	evaluated
T23	Negative_regulation 1530 1537	decline
E5	Negative_regulation:T23 Theme:E13
N24	Reference E5 UMLS:C3463820	Inhibition
N45	Reference E15 UMLS:C0035245	Respiratory physiology
T27	Biological_process 1519 1529	functional
E13	Biological_process:T27 Theme:T69
N48	Reference E13 UMLS:C0035245	Respiratory physiology
T30	Biological_process 1541 1546	death
E14	Biological_process:T30 Theme:T69
N49	Reference E14 UMLS:C0011065	Cessation of life
R17	member_of Arg1:T115 Arg2:T59	
R18	member_of Arg1:T20 Arg2:T29	
R19	Subject_Disorder Arg1:T69 Arg2:T1	
R20	member_of Arg1:T118 Arg2:T65	
R21	member_of Arg1:T117 Arg2:T65	
R22	member_of Arg1:T43 Arg2:T65	
R23	member_of Arg1:T79 Arg2:T65	
R24	member_of Arg1:T87 Arg2:T65	
R25	member_of Arg1:T48 Arg2:T65	
R26	member_of Arg1:T38 Arg2:T65	
R27	member_of Arg1:T126 Arg2:T65	
R28	part_of Arg1:T36 Arg2:T80	
R29	part_of Arg1:T36 Arg2:T56	
T33	Disorder 947 950	SSc
T44	Disorder 1070 1073	SSc
R30	Subject_Disorder Arg1:T67 Arg2:T33	
R31	Disorder_association Arg1:T33 Arg2:T72	
R32	Disorder_association Arg1:T44 Arg2:T61	
T50	Biological_process 43 53	functional
E16	Biological_process:T50 
N58	Reference E16 UMLS:C0035245	Respiratory physiology
T57	Negative_regulation 54 61	decline
E17	Negative_regulation:T57 Theme:E16 disorder:T103
N60	Reference E17 UMLS:C3463820	Inhibition
N10	Reference T9 UMLS:C0036421	Systemic Scleroderma
N13	Reference T22 UMLS:C0036421	Systemic Scleroderma
N19	Reference T33 UMLS:C0036421	Systemic Scleroderma
N27	Reference T44 UMLS:C0036421	Systemic Scleroderma
N39	Reference E2 UMLS:C0087111	Therapeutic procedure
T12	Disorder 1687 1690	SSc
N56	Reference T12 UMLS:C0036421	Systemic Scleroderma
R11	Disorder_association Arg1:T12 Arg2:T104	
